Broadridge Financial Solutions, INC Form 4 insider transactions
NYSE
Annette Nazareth, a Director at Broadridge Financial Solutions, Inc., acquired additional Deferred Stock Units on July 2, 2026, related to dividend payments.
NYSE
Broadridge Financial Solutions, Inc. reports a Form 4 filing detailing director Amit Zavery's acquisition of additional Deferred Stock Units.
NYSE
Ashima Ghei, CFO of Broadridge Financial Solutions, Inc., reported transactions involving the vesting and sale of company stock.
NYSE
Broadridge Financial Solutions, Inc. reports a director's acquisition of 206 Deferred Stock Units under the 2018 Omnibus Award Plan.
NYSE
Markus Maura, a Director at Broadridge Financial Solutions, Inc., has acquired 239 Deferred Stock Units (DCUs) under the company's 2018 Omnibus Award Plan.
NYSE
Broadridge Financial Solutions, Inc. reports that Director Amit Zavery acquired 206 Deferred Stock Units on June 10, 2026.
NYSE
Annette L. Nazareth, a Director at Broadridge Financial Solutions, Inc., acquired 206 Deferred Stock Units (DCUs) on June 10, 2026, as part of a compensation deferral plan.
NYSE
Eileen K. Murray, a Director at Broadridge Financial Solutions, Inc., acquired 445 Deferred Stock Units (DCUs) on June 10, 2026, as part of a compensation deferral plan.
NYSE
Chief Legal Officer Hope Jarkowski sold 1,966 shares of Broadridge Financial Solutions common stock on June 4, 2026.
NYSE
Broadridge Financial Solutions, Inc. reports that Director Amit Zavery acquired additional deferred stock units on April 8, 2026, related to dividend payments on existing units.
NYSE
Annette L. Nazareth, a Director at Broadridge Financial Solutions, Inc., acquired additional Deferred Stock Units through a dividend reinvestment program.
NYSE
Eileen K. Murray, a Director at Broadridge Financial Solutions, Inc., was awarded additional Deferred Stock Units on April 8, 2026, related to dividend payments.
NYSE
Broadridge Financial Solutions reports a director's acquisition of deferred stock units, reflecting dividend reinvestment under the company's incentive plan.
NYSE
Markus Maura, a Director at Broadridge Financial Solutions, Inc., acquired 116 Deferred Stock Units through dividend equivalents on April 8, 2026.
NYSE
Director Brett Keller of Broadridge Financial Solutions, Inc. acquired additional Deferred Stock Units through a dividend reinvestment plan.
NYSE
Broadridge Financial Solutions director Melvin L. Flowers was awarded 16 Deferred Stock Units on April 8, 2026, related to dividend payments.
NYSE
Robert N. Duelks, a Director at Broadridge Financial Solutions, Inc., acquired 127 Deferred Stock Units on April 8, 2026, related to dividend payments.
NYSE
Markus Maura, a Director at Broadridge Financial Solutions, Inc., acquired 206 Deferred Stock Units (DCUs) on April 7, 2026, as part of a compensation deferral plan.
NYSE
Broadridge Financial Solutions, Inc. reports that Director Amit Zavery acquired 177 Deferred Stock Units (DCUs) on April 7, 2026, as part of a compensation deferral plan.
NYSE
Annette L. Nazareth, a Director at Broadridge Financial Solutions, Inc., acquired 177 Deferred Stock Units (DCUs) on April 7, 2026, as part of a director compensation deferral plan.
NYSE
Eileen K. Murray, a Director at Broadridge Financial Solutions, Inc., reported a transaction involving the acquisition of Deferred Stock Units.
NYSE
Broadridge Financial Solutions, Inc. reports director Brett Keller's acquisition of 177 Deferred Stock Units.
NYSE
Chief Legal Officer Hope Jarkowski acquired 2,879 shares of Broadridge Financial Solutions through the vesting of restricted stock units.
NYSE
Broadridge Financial Solutions' Corporate VP and CHRO, Richard John Stingi, was granted 10,039 stock options with an exercise price of $190.89.
NYSE
Christopher John Perry, President and Director of Broadridge Financial Solutions, Inc., was granted 51,047 stock options.
NYSE
Broadridge Financial Solutions' Chief Legal Officer, Hope M. Jarkowski, was granted 20,872 stock options with an exercise price of $190.89.
NYSE
Broadridge Financial Solutions CEO Timothy C. Gokey was granted 170,667 stock options with an exercise price of $190.89, vesting over four years.
NYSE
Broadridge Financial Solutions' Interim CFO, Ashima Ghei, was granted 23,254 stock options with an exercise price of $190.89, vesting over four years.
NYSE
Broadridge Financial Solutions' Co-President ICS, Douglas Richard Deschutter, was granted 25,977 stock options with an exercise price of $190.89, vesting over four years.
NYSE
Broadridge Financial Solutions Corporate VP Thomas P Carey was granted 25,977 stock options with an exercise price of $190.89, vesting over four years.